JP2023537951A5 - - Google Patents

Info

Publication number
JP2023537951A5
JP2023537951A5 JP2023509532A JP2023509532A JP2023537951A5 JP 2023537951 A5 JP2023537951 A5 JP 2023537951A5 JP 2023509532 A JP2023509532 A JP 2023509532A JP 2023509532 A JP2023509532 A JP 2023509532A JP 2023537951 A5 JP2023537951 A5 JP 2023537951A5
Authority
JP
Japan
Prior art keywords
amino acid
peptide
hydrogel
preparation
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023509532A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023537951A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/045265 external-priority patent/WO2022035779A1/en
Publication of JP2023537951A publication Critical patent/JP2023537951A/ja
Publication of JP2023537951A5 publication Critical patent/JP2023537951A5/ja
Pending legal-status Critical Current

Links

JP2023509532A 2020-08-10 2021-08-09 自己組織化両親媒性ペプチドハイドロゲル Pending JP2023537951A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063063743P 2020-08-10 2020-08-10
US63/063,743 2020-08-10
PCT/US2021/045265 WO2022035779A1 (en) 2020-08-10 2021-08-09 Self-assembling amphiphilic peptide hydrogels

Publications (2)

Publication Number Publication Date
JP2023537951A JP2023537951A (ja) 2023-09-06
JP2023537951A5 true JP2023537951A5 (https=) 2024-08-16

Family

ID=80247353

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509532A Pending JP2023537951A (ja) 2020-08-10 2021-08-09 自己組織化両親媒性ペプチドハイドロゲル

Country Status (9)

Country Link
US (1) US20240398868A1 (https=)
EP (1) EP4192365A4 (https=)
JP (1) JP2023537951A (https=)
KR (1) KR20230042597A (https=)
CN (1) CN116390691A (https=)
AU (1) AU2021324962A1 (https=)
BR (1) BR112023002562A2 (https=)
CA (1) CA3188243A1 (https=)
WO (1) WO2022035779A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116347980A (zh) * 2020-08-10 2023-06-27 歌尔4梅德股份有限公司 自组装的两亲性肽水凝胶的局部和肠外使用和施用
EP4384532A4 (en) * 2021-08-09 2025-07-02 Gel4Med Inc SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS FOR THE TREATMENT OF NERVE INJURY
CN116139248A (zh) * 2022-11-18 2023-05-23 中国科学院过程工程研究所 一种肽水凝胶、其制备方法及其在治疗中的应用
CN120051309A (zh) * 2022-12-23 2025-05-27 矩阵(天津)生物科技有限公司 微球填充剂及其应用
CN116178498B (zh) * 2023-03-16 2025-04-01 赛克赛斯生物科技股份有限公司 一种自组装多肽及其应用
WO2025015030A1 (en) * 2023-07-10 2025-01-16 Kansas State University Research Foundation Peptide hydrogels, compositions, and conditions for scalable 3d cell manufacturing and applications
GB2633392A (en) * 2023-09-08 2025-03-12 Univ Warwick Protein storage gel
WO2025060949A1 (zh) * 2023-09-21 2025-03-27 纽泰(天津)生物科技有限公司 自组装肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664913B2 (en) * 1992-08-13 1995-12-07 Implico B.V. A hydrogel composition and methods of making it
EP2308522A3 (en) * 1999-11-17 2012-02-29 Boston Scientific Limited Microfabricated devices for the delivery of molecules into a carrier fluid
GB2362100B (en) * 2000-05-08 2002-05-08 Maelor Pharmaceuticals Ltd Wound gels
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
EP1962870A4 (en) * 2005-11-14 2010-08-11 Univ Delaware Technology Corp NEW HYDROGELS AND USES THEREOF
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
AU2011264834B2 (en) * 2010-06-09 2015-03-12 Semprus Biosciences Corp. Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
JP6554121B2 (ja) * 2014-03-10 2019-07-31 株式会社スリー・ディー・マトリックス 気管支閉鎖剤としての自己組織化ペプチド
WO2016004216A2 (en) * 2014-07-01 2016-01-07 Vicus Therapeutics, Llc Hydrogels for treating and ameliorating infections and methods of making and using them
CA3089396A1 (en) * 2018-02-10 2019-08-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nanoparticle-hydrogel composite for nucleic acid molecule delivery

Similar Documents

Publication Publication Date Title
JP2023537951A5 (https=)
JP2022514618A5 (https=)
JP2022542291A5 (https=)
JP2015502991A5 (https=)
JP2022518210A5 (https=)
JP2022517040A5 (https=)
JP2022513223A5 (https=)
JP2021505605A (ja) 5.8〜8.5のpIを有する少なくとも1つの基礎インスリン、および、カルボキシレート電荷および疎水性ラジカルを有するコポリアミノ酸を含むpH7を有する注射溶液
JP2022514255A5 (https=)
JP2004537581A5 (https=)
US11945846B2 (en) Stapled intracellular-targeting antimicrobial peptides to treat infection
JP2015532283A5 (https=)
CA2989311A1 (en) Stabilized anti-microbial peptides
FI2970398T3 (fi) Rsv f -prefuusioproteiineja ja niiden käyttö
JP2013155195A5 (https=)
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
JP2017501136A5 (https=)
WO2014027012A1 (en) Method for producing a composition for treating a tooth lesion
JP2010536714A5 (https=)
RU2010111139A (ru) Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства
JP2009533355A5 (https=)
WO2003048192A1 (en) Novel peptides and medicinal uses thereof
JP2018531284A (ja) 環状ポリペプチド、それらを得る方法、及びその治療的使用
JP2018531284A6 (ja) 環状ポリペプチド、それらを得る方法、及びその治療的使用
JP3786533B2 (ja) ペプチド及び骨形成促進剤